Chonluten

Chonluten is a synthetic tetrapeptide (Thr-Glu-Asp-Gly) belonging to the Khavinson class of bioregulatory peptides developed at the Saint Petersburg Institute of Bioregulation and Gerontology. It is designed to target pulmonary (lung) tissue through proposed peptide-DNA interactions that modulate gene expression in respiratory epithelial cells. Chonluten is studied alongside Bronchogen as part of the respiratory bioregulator family, though each peptide has a distinct amino acid sequence and proposed tissue specificity within the respiratory system. The Khavinson model proposes that Chonluten influences transcription of genes involved in lung tissue maintenance, surfactant biology, and respiratory epithelial homeostasis. It has been investigated in Russian biogerontology research examining age-related changes in pulmonary function and lung tissue gene expression.

Chonluten has been investigated for its proposed interactions with gene regulatory regions in pulmonary tissue cells. The Khavinson bioregulatory model proposes that the Thr-Glu-Asp-Gly sequence penetrates cell membranes and interacts with specific DNA sequences in promoter regions of lung-expressed genes. Researchers have observed that Chonluten treatment in respiratory cell culture models was associated with changes in expression of genes involved in surfactant production, mucociliary clearance, and epithelial barrier function. Studies from the Saint Petersburg group suggest that the peptide may influence lung tissue homeostasis through epigenetic modulation of chromatin structure, allowing or restricting access to specific gene promoters. In aging models, researchers observed that Chonluten administration was associated with changes in respiratory tissue morphology markers and proliferative indices. The peptide’s effects are attributed to direct peptide-DNA interactions rather than conventional cell-surface receptor signaling.

Pulmonary Gene Expression

Khavinson et al. (2014) investigated short peptides including Chonluten in bronchial epithelial cell models. Researchers observed changes in gene expression profiles related to respiratory function and epithelial differentiation following peptide treatment [1].

Bioregulatory Peptide Model

Khavinson VK (2002) presented the comprehensive framework for tissue-specific bioregulatory peptides, including those targeting pulmonary tissue, describing preclinical evidence for their gene-regulatory activity [2].

Respiratory Bioregulators

Khavinson et al. (2010) reviewed the effects of respiratory-targeted bioregulatory peptides on lung tissue markers in aging models, providing context for Chonluten’s place in the respiratory bioregulator class [3].